Inspire Medical Systems (INSP) Non-Current Assets (2017 - 2026)
Inspire Medical Systems (INSP) reported Non-Current Assets of $344.6 million for Q1 2026, up 116.53% on a YoY basis from $159.1 million in Q1 2025, and up 6.45% sequentially from $323.7 million in Q4 2025.
Inspire Medical Systems (INSP) Non-Current Assets (2017 - 2026) Analysis & Trends
Inspire Medical Systems (INSP) has 10 years of Non-Current Assets data on file, last reported at $344.6 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Assets rose 116.53% year-over-year to $344.6 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 billion (up 66.53% YoY), and the FY2025 full-year result was $323.7 million, up 82.27% from the prior year.
- Non-Current Assets grew to $344.6 million in Q1 2026, from $323.7 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $344.6 million in Q1 2026 to a low of $27.2 million in Q1 2022.
- A 5-year average of $133.9 million and a median of $113.6 million in 2024 frame the typical range for Non-Current Assets.
- Across the five-year window, Non-Current Assets soared 205.67% in 2024 and increased 3.53% in 2025, its largest moves.
- Tracing INSP's Non-Current Assets over 5 years: stood at $34.8 million in 2022, then jumped by 138.41% to $83.1 million in 2023, then jumped by 113.76% to $177.6 million in 2024, then surged by 82.27% to $323.7 million in 2025, then increased by 6.45% to $344.6 million in 2026.
- Business Quant data shows INSP's Non-Current Assets at $344.6 million in Q1 2026, $323.7 million in Q4 2025, and $221.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.30 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 20.47 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 6.35 Bn |
| 10 | Inspire Medical Systems | 1.46 Bn | 1.17 Bn | 176.91 Mn | 344.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 344.56 Mn |
| Dec 31, 2025 | 323.67 Mn |
| Sep 30, 2025 | 221.23 Mn |
| Jun 30, 2025 | 229.00 Mn |
| Mar 31, 2025 | 159.13 Mn |
| Dec 31, 2024 | 177.58 Mn |
| Sep 30, 2024 | 213.67 Mn |
| Jun 30, 2024 | 121.23 Mn |
| Mar 31, 2024 | 113.63 Mn |
| Dec 31, 2023 | 83.07 Mn |
| Sep 30, 2023 | 69.90 Mn |
| Jun 30, 2023 | 58.17 Mn |
| Mar 31, 2023 | 38.27 Mn |
| Dec 31, 2022 | 34.84 Mn |
| Sep 30, 2022 | 31.98 Mn |
| Jun 30, 2022 | 28.87 Mn |
| Mar 31, 2022 | 27.24 Mn |
| Dec 31, 2021 | 26.55 Mn |
| Sep 30, 2021 | 23.40 Mn |
| Jun 30, 2021 | 22.71 Mn |